Pai Satvik N, Jeyaraman Madhan, Jeyaraman Naveen, Yadav Sankalp
Orthopaedics, People's Education Society (PES) University Institute of Medical Sciences and Research, Bengaluru, IND.
Clinical Research Associate, Viriginia Tech India, Dr MGR Educational and Research Institute, Chennai, IND.
Cureus. 2024 Jul 16;16(7):e64692. doi: 10.7759/cureus.64692. eCollection 2024 Jul.
Blood donation, a fundamental act of altruism, has undergone significant evolution over the centuries. Despite medical progress, the persistent challenge lies in securing an adequate supply of blood and its derivatives. This article critically examines the proposal to introduce monetary incentives for blood donation, delving into ethical, legal, and pragmatic dimensions. India's current framework staunchly upholds voluntary, unpaid donations. However, global practices diverge significantly. Notably, India previously permitted monetary compensation for blood donation but later prohibited it due to concerns about infection transmission. Monetary incentives offer a potential solution to address key deterrents faced by potential donors. Health anxieties, time constraints, and fear of infection often discourage voluntary donations. By providing financial motivation, we may enhance donor participation and bolster the reliability of the blood supply. While the benefits are evident, caution is essential. Implementing monetary incentives necessitates robust safeguards. Preventing the exploitation of vulnerable populations and ensuring the safety of blood products remain paramount. Striking this delicate balance requires careful consideration. By analyzing ethical, legal, and practical facets, we navigate the intricate landscape of blood supply management.
献血，这一利他主义的基本行为，在几个世纪中经历了重大演变。尽管医学取得了进步，但持续存在的挑战在于确保充足的血液及其衍生物供应。本文批判性地审视了为献血引入金钱激励措施的提议，深入探讨了伦理、法律和实际层面的问题。印度目前的框架坚定支持自愿无偿献血。然而，全球做法差异显著。值得注意的是，印度此前允许对献血给予金钱补偿，但后来由于担心感染传播而予以禁止。金钱激励措施为解决潜在献血者面临的关键阻碍提供了一个潜在解决方案。健康焦虑、时间限制以及对感染的恐惧常常阻碍自愿献血。通过提供经济动机，我们或许可以提高献血者的参与度并增强血液供应的可靠性。虽然好处显而易见，但谨慎至关重要。实施金钱激励措施需要强有力的保障措施。防止对弱势群体的剥削以及确保血液制品的安全仍然至关重要。达成这种微妙的平衡需要仔细考量。通过分析伦理、法律和实际方面，我们在血液供应管理的复杂领域中前行。
